Lista de obras - Jun Zhang - Dominio Público Uruguay

A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.

artículo científico publicado en 2005

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway

artículo científico publicado en 2018

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.

artículo científico publicado en 2017

A novel immunoassay for PreS1 and/or core-related antigens for detection of HBsAg variants

artículo científico publicado en 2010

A rapid test for the detection of influenza A virus including pandemic influenza A/H1N1 2009.

artículo científico publicado en 2010

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

scientific article published on 29 March 2019

A valuable antigen detection method for diagnosis of acute hepatitis E.

artículo científico publicado en 2014

Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein.

artículo científico publicado en 2005

Antibody reactivity of conformational peptide mimics of a conserved H5N1 neutralization site in different fusion proteins

article

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

scientific article published on 28 March 2020

Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity.

artículo científico publicado en 2012

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.

artículo científico publicado en 2012

Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization

scientific article published on 05 November 2018

Calcium phosphate nanoparticles as a new generation vaccine adjuvant

artículo científico publicado en 2017

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

artículo científico publicado en 2022

Characterization of the SARS-CoV-2 Spike in an Early Prefusion Conformation

scientific article (preprint)

Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection

artículo científico publicado en 2017

Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment

artículo científico publicado en 2015

Construction and characterization of the chimeric antibody 8C11 to the hepatitis E virus.

artículo científico publicado en 2007

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus

artículo científico publicado en 2017

Development of a novel baculovirus titration method using the Enzyme-linked immunosorbent spot (ELISPOT) assay.

artículo científico publicado en 2012

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

artículo científico publicado en 2016

Development of an IgM-capture ELISA for Coxsackievirus A16 infection

artículo científico publicado en 2010

Development of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3.

artículo científico publicado en 2014

Development of an enzyme-linked immunospot assay for determination of rotavirus infectivity

artículo científico publicado en 2014

Development of the hepatitis E vaccine: from bench to field.

artículo científico

Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity.

artículo científico publicado en 2007

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10

artículo científico publicado en 2018

EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.

artículo científico publicado en 2017

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

artículo científico publicado en 2010

Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways

artículo científico publicado en 2017

Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma

artículo científico publicado en 2018

Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection

artículo científico publicado en 2015

Evaluation of a rapid test for detection of H5N1 avian influenza virus.

artículo científico publicado en 2008

Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model.

artículo científico publicado en 2003

Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products ⬇️

artículo científico publicado el 1 de octubre de 2003

Functional assessment and structural basis of antibody binding to human papillomavirus capsid

artículo científico

Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent

artículo científico publicado en 2020

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation

scientific article published on 30 January 2019

Hepatitis E vaccine development: a 14 year odyssey.

artículo científico publicado en 2012

High-Efficiency Plasma Separator Based on Immunocapture and Filtration

scientific article published on 28 March 2020

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody

artículo científico publicado en 2015

Identification of Strategic Residues at the Interface of Antigen-Antibody Interactions by In Silico Mutagenesis

artículo científico publicado en 2017

Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial

artículo científico publicado en 2015

Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system

artículo científico publicado en 2017

Induction of cross-reactive antibodies against mimotopes of H5N1 hemagglutinin

artículo científico publicado en 2010

Intratumoral Delivery of a PD-1-blocking scFv encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade

artículo científico publicado en 2020

Investigation of a special neutralizing epitope of HEV E2s.

artículo científico publicado en 2014

Lessons from hepatitis E vaccine design

artículo científico

Long-Term immunopersistence and safety of the <i>Escherichia coli</i>-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls

scientific article published in 2022

Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors.

artículo científico publicado en 2018

Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks

artículo científico publicado en 2020

Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I".

artículo científico publicado en 2010

Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.

artículo científico publicado en 2009

Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine

scholarly article by Xin Wang et al published 2 November 2018 in Vaccine

Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid.

artículo científico publicado en 2004

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

artículo científico publicado en 2020

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

scientific article published on 01 January 2019

Novel double-antigen sandwich immunoassay for human hepatitis B core antibody

artículo científico publicado en 2010

Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection

artículo científico publicado en 2018

Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg ⬇️

artículo científico publicado el 1 de mayo de 2003

Peptide mimics of a conserved H5N1 avian influenza virus neutralization site

artículo científico publicado en 2009

Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis

artículo científico publicado en 2010

Profile of acute infectious markers in sporadic hepatitis E.

artículo científico publicado en 2010

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation

artículo científico publicado en 2020

Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.

artículo científico publicado en 2014

Protective immunity against HEV.

artículo científico publicado en 2013

Putative receptor-binding sites of hepatitis E virus.

artículo científico publicado en 2008

Quantitative and epitope-specific antigenicity analysis of the human papillomavirus 6 capsid protein in aqueous solution or when adsorbed on particulate adjuvants

artículo científico publicado en 2016

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

artículo científico publicado en 2020

Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients.

artículo científico publicado en 2012

Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

artículo científico publicado en 2009

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

artículo científico publicado en 2020

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity

artículo científico publicado en 2018

Rationally respond to post-vaccination adverse events

artículo científico publicado en 2014

Real-time stability of a hepatitis E vaccine (Hecolin®) demonstrated with potency assays and multifaceted physicochemical methods.

artículo científico publicado en 2016

Resveratrol induces autophagy-dependent apoptosis in HL-60 cells.

artículo científico publicado en 2018

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).

artículo científico publicado en 2014

Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells

artículo científico publicado en 2020

SARS-CoV-2 spike produced in insect cells elicits high neutralization titers in non-human primates

artículo científico publicado en 2020

Safety and immunogenicity of an <i>Escherichia coli</i>-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial

scientific article published in 2022

Sex differences in the incidence and clearance of anal human papillomavirus infection among heterosexual men and women in Liuzhou, China: An observational cohort study

article

Significance of NF-κB activation in immortalization of nasopharyngeal epithelial cells.

artículo científico publicado en 2015

Specific cellular immune response in hepatitis E patients

artículo científico publicado en 2008

Specific interaction between hnRNP H and HPV16 L1 proteins: implications for late gene auto-regulation enabling rapid viral capsid protein production.

artículo científico publicado en 2012

Structures of pseudorabies virus capsids

artículo científico publicado en 2022

Swine as a principal reservoir of hepatitis E virus that infects humans in eastern China.

artículo científico publicado en 2006

The development of a recombinant hepatitis E vaccine HEV 239.

artículo científico publicado en 2015

The prevalence and concordance of human papillomavirus infection in different anogenital sites among men and women in Liuzhou, China: A population-based study

artículo científico publicado en 2017

Transfusion of plasma from a blood donor induced hepatitis E in Rhesus monkey.

artículo científico publicado en 2004

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

artículo científico publicado en 2020

Viral neutralization by antibody-imposed physical disruption

scientific article published on 09 December 2019

Lista de obras de Jun Zhang

A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.

A novel immunoassay for PreS1 and/or core-related antigens for detection of HBsAg variants

A rapid test for the detection of influenza A virus including pandemic influenza A/H1N1 2009.

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

A valuable antigen detection method for diagnosis of acute hepatitis E.

Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein.

Antibody reactivity of conformational peptide mimics of a conserved H5N1 neutralization site in different fusion proteins

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity.

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.

Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization

Calcium phosphate nanoparticles as a new generation vaccine adjuvant

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

Characterization of the SARS-CoV-2 Spike in an Early Prefusion Conformation

Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection

Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment

Construction and characterization of the chimeric antibody 8C11 to the hepatitis E virus.

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus

Development of a novel baculovirus titration method using the Enzyme-linked immunosorbent spot (ELISPOT) assay.

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

Development of an IgM-capture ELISA for Coxsackievirus A16 infection

Development of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3.

Development of an enzyme-linked immunospot assay for determination of rotavirus infectivity

Development of the hepatitis E vaccine: from bench to field.

Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity.

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10

EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways

Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma

Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection

Evaluation of a rapid test for detection of H5N1 avian influenza virus.

Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model.

Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products ⬇️

Functional assessment and structural basis of antibody binding to human papillomavirus capsid

Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation

Hepatitis E vaccine development: a 14 year odyssey.

High-Efficiency Plasma Separator Based on Immunocapture and Filtration

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody

Identification of Strategic Residues at the Interface of Antigen-Antibody Interactions by In Silico Mutagenesis

Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial

Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system

Induction of cross-reactive antibodies against mimotopes of H5N1 hemagglutinin

Intratumoral Delivery of a PD-1-blocking scFv encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade

Investigation of a special neutralizing epitope of HEV E2s.

Lessons from hepatitis E vaccine design

Long-Term immunopersistence and safety of the <i>Escherichia coli</i>-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls

Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors.

Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks

Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I".

Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.

Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine

Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid.

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

Novel double-antigen sandwich immunoassay for human hepatitis B core antibody

Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection

Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg ⬇️

Peptide mimics of a conserved H5N1 avian influenza virus neutralization site

Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis

Profile of acute infectious markers in sporadic hepatitis E.

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation

Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.

Protective immunity against HEV.

Putative receptor-binding sites of hepatitis E virus.

Quantitative and epitope-specific antigenicity analysis of the human papillomavirus 6 capsid protein in aqueous solution or when adsorbed on particulate adjuvants

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients.

Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity

Rationally respond to post-vaccination adverse events

Real-time stability of a hepatitis E vaccine (Hecolin®) demonstrated with potency assays and multifaceted physicochemical methods.

Resveratrol induces autophagy-dependent apoptosis in HL-60 cells.

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).

Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells